{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:40:39Z","timestamp":1791499239471,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472083"],"award-info":[{"award-number":["81472083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cellular therapy based on mesenchymal stem cells (MSCs) is a promising novel therapeutic strategy for the osteonecrosis of the femoral head (ONFH), which is gradually becoming popular, particularly for early-stage ONFH. Nonetheless, the MSC-based therapy is challenging due to certain limitations, such as limited self-renewal capability of cells, availability of donor MSCs, and the costs involved in donor screening. As an alternative approach, MSCs derived from induced pluripotent stem cells (iPSCs), which may lead to further standardized-cell preparations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In the present study, the bone marrow samples of patients with ONFH (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916) and patients with the fracture of the femoral neck (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) were obtained during operation. The bone marrow-derived MSCs (BMSCs) were isolated by density gradient centrifugation. BMSCs of ONFH patients (ONFH-BMSCs) were reprogrammed to iPSCs, following which the iPSCs were differentiated into MSCs (iPSC-MSCs). Forty adult male rats were randomly divided into following groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910 per group): (a) normal control group, (b) methylprednisolone (MPS) group, (c) MPS\u2009+\u2009BMSCs treated group, and (d) MPS\u2009+\u2009iPSC-MSC-treated group. Eight weeks after the establishment of the ONFH model, rats in BMSC-treated group and iPSC-MSC-treated group were implanted with BMSCs and iPSC-MSCs through intrabone marrow injection. Bone repair of the femoral head necrosis area was analyzed after MSC transplantation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The morphology, immunophenotype, in vitro differentiation potential, and DNA methylation patterns of iPSC-MSCs were similar to those of normal BMSCs, while the proliferation of iPSC-MSCs was higher and no tumorigenic ability was exhibited. Furthermore, comparing the effectiveness of iPSC-MSCs and the normal BMSCs in an ONFH rat model revealed that the iPSC-MSCs was equivalent to normal BMSCs in preventing bone loss and promoting bone repair in the necrosis region of the femoral head.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Reprogramming can reverse the abnormal proliferation, differentiation, and DNA methylation patterns of ONFH-BMSCs. Transplantation of iPSC-MSCs could effectively promote bone repair and angiogenesis in the necrosis area of the femoral head.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02249-1","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:03:14Z","timestamp":1615510994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head"],"prefix":"10.1186","volume":"12","author":[{"given":"Meiling","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoya","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denglong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-5610","authenticated-orcid":false,"given":"Shunan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"2249_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5435\/00124635-199907000-00005","volume":"7","author":"CJ Lavernia","year":"1999","unstructured":"Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg. 1999;7:250\u201361.","journal-title":"J Am Acad Orthop Surg"},{"key":"2249_CR2","first-page":"3127","volume":"8","author":"C Wang","year":"2015","unstructured":"Wang C, Wang Y, Meng HY, Yuan XL, Xu XL, Wang AY, et al. Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head. Int J Clin Exp Med. 2015;8:3127\u201335.","journal-title":"Int J Clin Exp Med"},{"key":"2249_CR3","first-page":"E186","volume":"40","author":"DF Amanatullah","year":"2011","unstructured":"Amanatullah DF, Strauss EJ, Di Cesare PE. Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management. Am J Orthop (Belle Mead NJ). 2011;40:E186\u201392.","journal-title":"Am J Orthop (Belle Mead NJ)."},{"key":"2249_CR4","first-page":"E216","volume":"40","author":"DF Amanatullah","year":"2011","unstructured":"Amanatullah DF, Strauss EJ, Di Cesare PE. Current management options for osteonecrosis of the femoral head: part II, operative management. Am J Orthop (Belle Mead NJ). 2011;40:E216\u201325.","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"2249_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5312\/wjo.v3.i5.49","volume":"3","author":"AP Kaushik","year":"2012","unstructured":"Kaushik AP, Das A, Cui Q. Osteonecrosis of the femoral head: an update in year 2012. World J Orthop. 2012;3:49\u201357.","journal-title":"World J Orthop"},{"key":"2249_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.bone.2015.09.012","volume":"81","author":"D Liu","year":"2015","unstructured":"Liu D, Li X, Li J, Yang J, Yokota H, Zhang P. Knee loading protects against osteonecrosis of the femoral head by enhancing vessel remodeling and bone healing. Bone. 2015;81:620\u201331.","journal-title":"Bone."},{"key":"2249_CR7","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.4103\/0366-6999.168017","volume":"128","author":"D Zhao","year":"2015","unstructured":"Zhao D, Yu M, Hu K, Wang W, Yang L, Wang B, et al. Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey. Chin Med J. 2015;128:2843\u201350.","journal-title":"Chin Med J"},{"key":"2249_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/BLO.0b013e3181591c92","volume":"465","author":"FA Petrigliano","year":"2007","unstructured":"Petrigliano FA, Lieberman JR. Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res. 2007;465:53\u201362.","journal-title":"Clin Orthop Relat Res"},{"key":"2249_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ocl.2004.02.007","volume":"35","author":"GC Babis","year":"2004","unstructured":"Babis GC, Soucacos PN. Effectiveness of total hip arthroplasty in the management of hip osteonecrosis. Orthop Clin North Am. 2004;35:359\u201364 x.","journal-title":"Orthop Clin North Am"},{"key":"2249_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1634\/stemcells.21-2-190","volume":"21","author":"HS Lee","year":"2003","unstructured":"Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH, et al. Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells. 2003;21:190\u20139.","journal-title":"Stem Cells"},{"key":"2249_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/jor.20078","volume":"24","author":"JS Lee","year":"2006","unstructured":"Lee JS, Lee JS, Roh HL, Kim CH, Jung JS, Suh KT. Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res. 2006;24:604\u20139.","journal-title":"J Orthop Res"},{"key":"2249_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bone.2009.09.001","volume":"46","author":"Y Feng","year":"2010","unstructured":"Feng Y, Yang SH, Xiao BJ, Xu WH, Ye SN, Xia T, et al. Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone. 2010;46:32\u201340.","journal-title":"Bone."},{"key":"2249_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5144\/0256-4947.2012.68","volume":"32","author":"A Aldahmash","year":"2012","unstructured":"Aldahmash A, Zaher W, Al-Nbaheen M, Kassem M. Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration. Ann Saudi Med. 2012;32:68\u201377.","journal-title":"Ann Saudi Med"},{"key":"2249_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.bbmt.2008.06.017","volume":"14","author":"KB Jones","year":"2008","unstructured":"Jones KB, Seshadri T, Krantz R, Keating A, Ferguson PC. Cell-based therapies for osteonecrosis of the femoral head. Biol Blood Marrow Transplant. 2008;14:1081\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2249_CR15","doi-asserted-by":"publisher","first-page":"8616143","DOI":"10.1155\/2016\/8616143","volume":"2016","author":"H Jin","year":"2016","unstructured":"Jin H, Xu T, Chen Q, Wu C, Wang P, Mao Q, et al. The fate and distribution of autologous bone marrow mesenchymal stem cells with intra-arterial infusion in osteonecrosis of the femoral head in dogs. Stem Cells Int. 2016;2016:8616143.","journal-title":"Stem Cells Int"},{"key":"2249_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.20452\/pamw.2355","volume":"124","author":"MZ Ratajczak","year":"2014","unstructured":"Ratajczak MZ, Jadczyk T, Pedziwiatr D, Wojakowski W. New advances in stem cell research: practical implications for regenerative medicine. Pol Arch Med Wewn. 2014;124:417\u201326.","journal-title":"Pol Arch Med Wewn"},{"key":"2249_CR17","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1177\/147323001103900528","volume":"39","author":"A Abudusaimi","year":"2011","unstructured":"Abudusaimi A, Aihemaitijiang Y, Wang YH, Cui L, Maimaitiming S, Abulikemu M. Adipose-derived stem cells enhance bone regeneration in vascular necrosis of the femoral head in the rabbit. J Int Med Res. 2011;39:1852\u201360.","journal-title":"J Int Med Res"},{"key":"2249_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1302\/0301-620X.81B2.0810349","volume":"81","author":"P Hernigou","year":"1999","unstructured":"Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999;81:349\u201355.","journal-title":"J Bone Joint Surg Br"},{"key":"2249_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00198-004-1649-7","volume":"16","author":"X Li","year":"2005","unstructured":"Li X, Jin L, Cui Q, Wang GJ, Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int. 2005;16:101\u20138.","journal-title":"Osteoporos Int"},{"key":"2249_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3928\/01477447-20080501-33","volume":"31","author":"BL Wang","year":"2008","unstructured":"Wang BL, Sun W, Shi ZC, Lou JN, Zhang NF, Shi SH, et al. Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head. Orthopedics. 2008;31:444.","journal-title":"Orthopedics."},{"key":"2249_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00003086-200212000-00003","volume":"405","author":"P Hernigou","year":"2002","unstructured":"Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14\u201323.","journal-title":"Clin Orthop Relat Res"},{"key":"2249_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/0019-5413.45322","volume":"43","author":"P Hernigou","year":"2009","unstructured":"Hernigou P, Poignard A, Zilber S, Rouard H. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop. 2009;43:40\u20135.","journal-title":"Indian J Orthop"},{"key":"2249_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bone.2011.11.002","volume":"50","author":"D Zhao","year":"2012","unstructured":"Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325\u201330.","journal-title":"Bone."},{"key":"2249_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bone.2013.08.022","volume":"57","author":"Q Mao","year":"2013","unstructured":"Mao Q, Jin H, Liao F, Xiao L, Chen D, Tong P. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study. Bone. 2013;57:509\u201316.","journal-title":"Bone."},{"key":"2249_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/hum.2019.306","volume":"31","author":"P Shu","year":"2020","unstructured":"Shu P, Sun DL, Shu ZX, Tian S, Pan Q, Wen CJ, et al. Therapeutic applications of genes and gene-engineered mesenchymal stem cells for femoral head necrosis. Hum Gene Ther. 2020;31:286\u201396.","journal-title":"Hum Gene Ther"},{"key":"2249_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13770-014-0410-3","volume":"11","author":"H Jung","year":"2014","unstructured":"Jung H, Ahn E, Lee JH, Kim YH, Leem S, Heo J, et al. Effects of harvesting sites and ages on adipose tissue-derived stem cells in rat. Tissue Eng Regen Med. 2014;11:137\u201342.","journal-title":"Tissue Eng Regen Med"},{"key":"2249_CR27","first-page":"284215","volume":"2015","author":"Y Sun","year":"2015","unstructured":"Sun Y, Deng W, Geng L, Zhang L, Liu R, Chen W, et al. Mesenchymal stem cells from patients with rheumatoid arthritis display impaired function in inhibiting Th17 cells. Clin Dev Immunol. 2015;2015:284215.","journal-title":"Clin Dev Immunol"},{"key":"2249_CR28","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.1038\/srep07144","volume":"4","author":"D Duscher","year":"2014","unstructured":"Duscher D, Rennert RC, Januszyk M, Anghel E, Maan ZN, Whittam AJ, et al. Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells. Sci Rep. 2014;4:7144.","journal-title":"Sci Rep"},{"key":"2249_CR29","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1089\/ten.tea.2010.0085","volume":"16","author":"BL Larson","year":"2010","unstructured":"Larson BL, Ylostalo J, Lee RH, Gregory C, Prockop DJ. Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A. 2010;16:3385\u201394.","journal-title":"Tissue Eng Part A"},{"key":"2249_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.febslet.2009.02.031","volume":"583","author":"D Taura","year":"2009","unstructured":"Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y, et al. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 2009;583:1029\u201333.","journal-title":"FEBS Lett"},{"key":"2249_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/sctm.17-0305","volume":"7","author":"S Soontararak","year":"2018","unstructured":"Soontararak S, Chow L, Johnson V, Coy J, Wheat W, Regan D, et al. Mesenchymal stem cells (MSC) derived from induced pluripotent stem cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model. Stem Cells Transl Med. 2018;7:456\u201367.","journal-title":"Stem Cells Transl Med"},{"key":"2249_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/cvr\/cvy207","volume":"115","author":"M Zhao","year":"2019","unstructured":"Zhao M, Fan C, Ernst PJ, Tang Y, Zhu H, Mattapally S, et al. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice. Cardiovasc Res. 2019;115:343\u201356.","journal-title":"Cardiovasc Res"},{"key":"2249_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","volume":"121","author":"Q Lian","year":"2010","unstructured":"Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010;121:1113\u201323.","journal-title":"Circulation."},{"key":"2249_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science."},{"key":"2249_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell."},{"key":"2249_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.stemcr.2014.07.003","volume":"3","author":"J Frobel","year":"2014","unstructured":"Frobel J, Hemeda H, Lenz M, Abagnale G, Joussen S, Denecke B, et al. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Reports. 2014;3:414\u201322.","journal-title":"Stem Cell Reports"},{"key":"2249_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002213","volume":"3","author":"W Wagner","year":"2008","unstructured":"Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3:e2213.","journal-title":"PLoS One"},{"key":"2249_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00198-014-2809-z","volume":"26","author":"ZB Sun","year":"2015","unstructured":"Sun ZB, Wang JW, Xiao H, Zhang QS, Kan WS, Mo FB, et al. Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study. Osteoporos Int. 2015;26:187\u201397.","journal-title":"Osteoporos Int"},{"key":"2249_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods."},{"key":"2249_CR40","doi-asserted-by":"publisher","first-page":"1340252","DOI":"10.1155\/2018\/1340252","volume":"2018","author":"W Zhun","year":"2018","unstructured":"Zhun W, Donghai L, Zhouyuan Y, Haiyan Z, Pengde K. Efficiency of cell therapy to GC-induced ONFH: BMSCs with Dkk-1 interference is not superior to unmodified BMSCs. Stem Cells Int. 2018;2018:1340252.","journal-title":"Stem Cells Int"},{"key":"2249_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12891-015-0589-z","volume":"16","author":"Y Dong","year":"2015","unstructured":"Dong Y, Li Y, Huang C, Gao K, Weng X. Systemic application of teriparatide for steroid induced osteonecrosis in a rat model. BMC Musculoskelet Disord. 2015;16:163.","journal-title":"BMC Musculoskelet Disord"},{"key":"2249_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3109\/03008201003597049","volume":"51","author":"M Ocarino Nde","year":"2010","unstructured":"Ocarino Nde M, Boeloni JN, Jorgetti V, Gomes DA, Goes AM, Serakides R. Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect Tissue Res. 2010;51:426\u201333.","journal-title":"Connect Tissue Res"},{"key":"2249_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.7150\/thno.17450","volume":"7","author":"SC Tao","year":"2017","unstructured":"Tao SC, Yuan T, Rui BY, Zhu ZZ, Guo SC, Zhang CQ. Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt\/Bad\/Bcl-2 signal pathway. Theranostics. 2017;7:733\u201350.","journal-title":"Theranostics."},{"key":"2249_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.gt.3303070","volume":"15","author":"D Sheyn","year":"2008","unstructured":"Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther. 2008;15:257\u201366.","journal-title":"Gene Ther"},{"key":"2249_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Blanc KL, Mueller I, Slapercortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy."},{"key":"2249_CR46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bone.2019.06.021","volume":"127","author":"J Wu","year":"2019","unstructured":"Wu J, Du Y, Song J, Dang X, Wang K, Wen Y, et al. Genome-wide DNA methylation profiling of hip articular cartilage identifies differentially methylated loci associated with osteonecrosis of the femoral head. Bone. 2019;127:296\u2013304.","journal-title":"Bone."},{"key":"2249_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7150\/ijbs.16951","volume":"13","author":"X Liu","year":"2017","unstructured":"Liu X, Li Q, Niu X, Hu B, Chen S, Song W, et al. Exosomes secreted from human-induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis. Int J Biol Sci. 2017;13:232\u201344.","journal-title":"Int J Biol Sci"},{"key":"2249_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1359\/jbmr.2002.17.3.384","volume":"17","author":"N Garcia-Giralt","year":"2002","unstructured":"Garcia-Giralt N, Nogu\u00e9s X, Enjuanes A, Puig J, Mellibovsky L, Bay-Jensen A, et al. Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density. J Bone Miner Res. 2002;17:384\u201393.","journal-title":"J Bone Miner Res"},{"key":"2249_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13287-018-1030-y","volume":"9","author":"JS Kang","year":"2018","unstructured":"Kang JS, Suh YJ, Moon KH, Park JS, Roh TH, Park MH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018;9:274.","journal-title":"Stem Cell Res Ther"},{"key":"2249_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.128","volume":"45","author":"YW Lim","year":"2013","unstructured":"Lim YW, Kim YS, Lee JW, Kwon SY. Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med. 2013;45:e61.","journal-title":"Exp Mol Med"},{"key":"2249_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.5966\/sctm.2015-0427","volume":"6","author":"CR Nitkin","year":"2017","unstructured":"Nitkin CR, Bonfield TL. Concise review: mesenchymal stem cell therapy for pediatric disease: perspectives on success and potential improvements. Stem Cells Transl Med. 2017;6:539\u201365.","journal-title":"Stem Cells Transl Med"},{"key":"2249_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12015-016-9695-z","volume":"13","author":"C Luzzani","year":"2017","unstructured":"Luzzani C, Miriuka S. Pluripotent stem cells as a robust source of mesenchymal stem cells. Stem Cell Rev Rep. 2017;13:68\u201378.","journal-title":"Stem Cell Rev Rep"},{"key":"2249_CR53","doi-asserted-by":"publisher","first-page":"146293","DOI":"10.1016\/j.brainres.2019.06.012","volume":"1720","author":"Y Yu","year":"2019","unstructured":"Yu Y, Wang D, Li H, Fan J, Liu Y, Zhao X, et al. Mesenchymal stem cells derived from induced pluripotent stem cells play a key role in immunomodulation during cardiopulmonary resuscitation. Brain Res. 2019;1720:146293.","journal-title":"Brain Res"},{"key":"2249_CR54","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/mt.2012.207","volume":"21","author":"K Shao","year":"2013","unstructured":"Shao K, Koch CM, Gupta M, Lin Q, Lenz M, Laufs S, et al. Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. Mol Ther. 2013;21:240\u201350.","journal-title":"Mol Ther"},{"key":"2249_CR55","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nbt.2052","volume":"29","author":"K Kim","year":"2011","unstructured":"Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol. 2011;29:1117\u20139.","journal-title":"Nat Biotechnol"},{"key":"2249_CR56","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1073\/pnas.1423008112","volume":"112","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Gregory CA, Lee RH, Reger RL, Qin L, Hai B, et al. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A. 2015;112:530\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2249_CR57","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/art.38713","volume":"66","author":"MD Rushton","year":"2014","unstructured":"Rushton MD, Reynard LN, Barter MJ, Refaie R, Rankin KS, Young D, et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheum. 2014;66:2450\u201360.","journal-title":"Arthritis Rheum"},{"key":"2249_CR58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.msec.2018.11.056","volume":"96","author":"YA Vorotnikov","year":"2019","unstructured":"Vorotnikov YA, Pozmogova TN, Solovieva AO, Miroshnichenko SM, Vorontsova EV, Shestopalova LV, et al. Luminescent silica mesoparticles for protein transduction. Mater Sci Eng C Mater Biol Appl. 2019;96:530\u20138.","journal-title":"Mater Sci Eng C Mater Biol Appl"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-021-02249-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T17:52:53Z","timestamp":1724608373000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02249-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02249-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the ethics committee of the Tongji Medical College, Huazhong University of Science and Technology (No: IORG0003571). Written informed consent for participation in the present study was obtained from each patient prior to collecting the bone marrow samples. All animal care and experimental procedures were in accordance with local and international guidelines on the ethical use of animals and were approved by the University Animal Welfare Committee, Tongji Medical College, Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors indicated no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}